Chengcheng Hao
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Osteopontin and Cancer: Insights into Its Role in Drug Resistance.
Journal: Biomedicines
Published: December 20, 2022
Effect of BRAF/MEK Inhibition on Epithelioid Glioblastoma with BRAFV600E Mutation: a Case Report and Review of the Literature.
Journal: Clinical laboratory
Published: August 11, 2020
PD-L1 Expression in Glioblastoma, the Clinical and Prognostic Significance: A Systematic Literature Review and Meta-Analysis.
Journal: Frontiers in oncology
Published: February 15, 2020
Autophagy inhibition of cancer stem cells promotes the efficacy of cisplatin against non-small cell lung carcinoma.
Journal: Therapeutic advances in respiratory disease
Published: August 02, 2019
OPN-a Splicing Variant Expression in Non-small Cell Lung Cancer and its Effects on the Bone Metastatic Abilities of Lung Cancer Cells In Vitro.
Journal: Anticancer research
Published: February 17, 2017
Human osteopontin: Potential clinical applications in cancer (Review).
Journal: International journal of molecular medicine
Published: January 03, 2017
NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway.
Journal: Oncotarget
Published: September 20, 2016
Prognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-Analysis.
Journal: BioMed research international
Published: April 20, 2016
A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.
Journal: Anticancer research
Published: March 16, 2016
Last Updated: 09/26/2026